Data from two of the four studies of Ki-67/MiB1 supported a predictive role in the prognosis of anal cancer patients treated with chemoradiotherapy (Grabenbauer et al, 1998; Ajani et al, 2009). This evidence concerns the gene MIB1 and anal carcinoma.